Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. In a new ...
U.S. FDA Approves Bristol Myers Squibb’s COBENFY, a First-In-Class Muscarinic Agonist for the Treatment of Schizophrenia in Adults ...
We wouldn’t allow a new drug to be sold without thorough testing for safety and efficacy, so why should AI be any different?
A growing body of research shows that exposure can increase the risk of prostate, kidney and testicular cancers. The ...
A report published Wednesday in The BMJ questioned the safety and effectiveness of the Alzheimer’s disease drug Kisunla ...
The Food and Drug Administration (FDA) is looking to propose the inclusion of front-of-package warning labels that detail the ...
Company requests Type A Meeting with U.S. Food and Drug Administration regarding clinical hold for CER-1236; announces key management ...
The Food and Drug Administration continues using import alerts to enforce U.S. food safety regulations for food from foreign ...